Pharmaceutical companies are facing big challenges due to potential tariffs and changing policies. While some, like Roche and Johnson & Johnson, are investing billions to expand U.S. manufacturing, many are still unsure about the future. A recent survey found that most industry leaders expect some impact on their business, but few have taken major steps yet. Experts say companies need to be ready to adapt quickly. Jay Bhatt from Deloitte compares this to how hospitals prepare for emergencies—by planning ahead and practicing responses. He suggests that drugmakers should operate in a flexible way, adjusting their strategies as new information comes in. This means using real-time data to make fast decisions, working across different teams, and staying ready for changes. The goal is to build resilience so companies can handle whatever comes next.